LMAT · NASDAQ · STOCK
LeMaitre Vascular, Inc.
$82.83
52W $78.65 – $118.01
57/100
$1.89B
28.6
0.52
Is LMAT Bullish or Bearish?
Mixed.
Innellis AI committee rates LeMaitre Vascular, Inc. (LMAT) Watch with a composite score of 57/100
, based on 6 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.24 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.76 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 38.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 34.4% YoY — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 28.6 is moderate-to-rich — Value
- Price-to-book of 4.7x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 38.2% signals elevated volatility — Risk
- News sentiment is negative (-0.20 across 10 articles, 14d) — News
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
57/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 72%
of 192 Healthcare peers
Value Analyst
neutral
54
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 16.4% shows genuine earnings power backing the valuation
− P/E of 28.6 is moderate-to-rich
Growth Analyst
bullish
75
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ EPS growing 34.4% YoY
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 38.2% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
51
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.20 across 10 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
31.2
Neutral
MACD Histogram
-2.385
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$81.71
Resistance
$91.56
Bollinger %B
0.14
Inside Bands
Price vs Moving Averages
EMA 9
$88.23
Below
EMA 21
$93.39
Below
EMA 50
$96.56
Below
EMA 200
$96.55
Below
Fundamental Analysis
Valuation
66
Profitability
92
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
28.6×
P/B Ratio
4.50×
PEG Ratio
0.75
Dividend Yield
1.09%
52W High
$118.01
52W Low
$78.65
Quality & Growth
ROE
1467.1%
ROA
937.7%
Gross Margin
7289.7%
Operating Margin
2946.2%
Revenue Growth YoY
—
Debt / Equity
0.45
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 28.6 (moderate relative to a 15-40x range); Price-to-book of 4.5x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 14.7%; Return on assets of 9.4%; Net margin of 25.0%; Gross margin of 72.9%; Current ratio of 16.31 (healthy short-term liquidity); Debt-to-equity of 0.45; Free cash flow per share is positive (3.23); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full LMAT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →